Press "Enter" to skip to content

GSK Chairman Philip Hampton To Step Down After Three-Year Stint

Before joining GSK, Hampton was chairman of Royal Bank of Scotland Group Plc and J Sainsbury plc

File photo of Philip Hampton (Reuters)

Loading…

GlaxoSmithKline Plc Chairman Philip Hampton will step down after more than three and a half years in the role, Britain’s biggest drugmaker announced on Monday.

The announcement comes a month after GSK’s Chief Executive Emma Walmsley announced her boldest plans yet – to split the company into two businesses — one for prescription drugs and vaccines, the other for over-the-counter products.

Walmsley, who took the helm in 2017, announced in December that GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 percent-owned by the British company, in an all-equity transaction.

“Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new Chair to oversee this process through to its conclusion over the next few years,” Hampton said in a statement.
Before joining GSK, Hampton was chairman of Royal Bank of Scotland Group Plc and J Sainsbury plc.

GSK, which is looking to buy early-stage assets and partner with companies, said it had started the search for a successor.

Catch the biggest newsmakers and the biggest newsbreaks on CNN-News18, the only news destination. Keep watching CNN-News18 at just 50 paise per month. Contact your cable/DTH operator now!

*Rental/capacity fee of Rs. 130/- as charged by cable/DTH operator may apply. **GST extra.

Source: News18